Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol for Ulcerated Hemangiomas
NCT01408056Phase 2Withdrawn
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Feb 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timolol maleate gel + placebo in infantile hemangioma (IH), sponsored by Children's Hospital of Philadelphia. Planned start Feb 2011; status: withdrawn.
02
Drugs
timolol maleate gel + placebo
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT01408056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408056.